Bellecapital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,100
| Closed | -$209K | – | 214 |
|
|
2021
Q4 | $209K | Hold |
26,100
| – | – | 0.06% | 186 |
|
|
2021
Q3 | $254K | Hold |
26,100
| – | – | 0.08% | 169 |
|
|
2021
Q2 | $258K | Hold |
26,100
| – | – | 0.08% | 164 |
|
|
2021
Q1 | $301K | Hold |
26,100
| – | – | 0.09% | 154 |
|
|
2020
Q4 | $252K | Buy |
26,100
+10,100
| +63% | +$97.5K | 0.08% | 163 |
|
|
2020
Q3 | $144K | Hold |
16,000
| – | – | 0.07% | 160 |
|
|
2020
Q2 | $197K | Hold |
16,000
| – | – | 0.09% | 154 |
|
|
2020
Q1 | $144K | Buy |
+16,000
| New | +$144K | 0.09% | 145 |
|
|
2019
Q4 | – | Sell |
-16,000
| Closed | -$110K | – | 157 |
|
|
2019
Q3 | $110K | Hold |
16,000
| – | – | 0.07% | 132 |
|
|
2019
Q2 | $148K | Hold |
16,000
| – | – | 0.09% | 121 |
|
|
2019
Q1 | $251K | Hold |
16,000
| – | – | 0.16% | 96 |
|
|
2018
Q4 | $247K | Hold |
16,000
| – | – | 0.18% | 86 |
|
|
2018
Q3 | $345K | Hold |
16,000
| – | – | 0.23% | 65 |
|
|
2018
Q2 | $389K | Buy |
+16,000
| New | +$389K | 0.28% | 57 |
|
|
2016
Q4 | – | Sell |
-6,600
| Closed | -$297K | – | 88 |
|
|
2016
Q3 | $297K | Hold |
6,600
| – | – | 0.33% | 51 |
|
|
2016
Q2 | $325K | Hold |
6,600
| – | – | 0.36% | 44 |
|
|
2016
Q1 | $340K | Buy |
6,600
+1,900
| +40% | +$97.9K | 0.45% | 39 |
|
|
2015
Q4 | $309K | Buy |
4,700
+700
| +18% | +$46K | 0.4% | 42 |
|
|
2015
Q3 | $226K | Hold |
4,000
| – | – | 0.33% | 41 |
|
|
2015
Q2 | $236K | Hold |
4,000
| – | – | 0.3% | 45 |
|
|
2015
Q1 | $249K | Hold |
4,000
| – | – | 0.33% | 43 |
|
|
2014
Q4 | $230K | Hold |
4,000
| – | – | 0.31% | 48 |
|
|
2014
Q3 | $215K | Hold |
4,000
| – | – | 0.25% | 48 |
|
|
2014
Q2 | $210K | Hold |
4,000
| – | – | 0.21% | 66 |
|
|
2014
Q1 | $211K | Buy |
+4,000
| New | +$211K | 0.18% | 73 |
|